Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Pharmacotherapy
|
July 26, 2017
Eteplirsen for the Treatment of Duchenne Muscular Dystrophy: Quality of Evidence Concerns-an Alternative Viewpoint
Adriane N Irwin, Megan C Herink
Pharmacotherapy
|
July 26, 2018
FDA Breakthrough Therapy Designation: Evaluating the Quality of the Evidence behind the Drug Approvals
Megan C Herink, Adriane N Irwin, Gregory M Zumach
Current Neurology and Neuroscience Reports
|
July 31, 2023
Polypharmacy in Multiple Sclerosis: Prevalence, Risks, and Mitigation Strategies
W Daniel Chapman, Megan C Herink, Michelle H Cameron, et al.
Journal of Managed Care & Specialty Pharmacy
|
June 29, 2021
Effect of relaxing hepatitis C treatment restrictions on direct-acting antiviral use in a Medicaid program: an interrupted time series analysis
Megan C Herink, Jonah Geddes, Kim Vo, et al.
Drugs
|
August 24, 2019
Clinical Management of Pharmacokinetic Drug Interactions with Direct Oral Anticoagulants (DOACs)
Megan C Herink, Yan F Zhuo, Craig D Williams, et al.
Systematic Reviews
|
April 16, 2015
The safety and efficacy of vortioxetine for acute treatment of major depressive disorder: a systematic review and meta-analysis
Amanda S Meeker, Megan C Herink, Dean G Haxby, et al.
Pharmacy (Basel, Switzerland)
|
October 26, 2022
Pharmacists' Knowledge and Perceptions of FDA Approval Standards and the Breakthrough Therapy Designation
Megan C Herink, Kirbee Johnston, Kristin Breninger, et al.
The Primary Care Companion for CNS Disorders
|
July 2, 2024
A 3-Times-Daily Dosing Scheme of Prazosin to Treat Posttraumatic Stress Disorder-Induced Psychological Distress in the Hospital
Kendall J Tucker, Trisha T Villanueva, Miles Fletcher, et al.
Pharmacotherapy
|
December 19, 2013
Evidence behind FDA alerts for drugs with adverse cardiovascular effects: implications for clinical practice
Daniel M Rackham, Megan C Herink, Ian G Stevens, et al.
Journal of Pharmacy Practice
|
March 17, 2023
Adherence to Hepatitis C Treatment Among Underserved Patients With Substance Use Disorder in a Pharmacist-led Treatment Model
Anthony J McKenzie, Brie N Noble, Megan C Herink, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Pharmacotherapy
|
July 26, 2017
Eteplirsen for the Treatment of Duchenne Muscular Dystrophy: Quality of Evidence Concerns-an Alternative Viewpoint
Adriane N Irwin, Megan C Herink
Pharmacotherapy
|
July 26, 2018
FDA Breakthrough Therapy Designation: Evaluating the Quality of the Evidence behind the Drug Approvals
Megan C Herink, Adriane N Irwin, Gregory M Zumach
Current Neurology and Neuroscience Reports
|
July 31, 2023
Polypharmacy in Multiple Sclerosis: Prevalence, Risks, and Mitigation Strategies
W Daniel Chapman, Megan C Herink, Michelle H Cameron, et al.
Journal of Managed Care & Specialty Pharmacy
|
June 29, 2021
Effect of relaxing hepatitis C treatment restrictions on direct-acting antiviral use in a Medicaid program: an interrupted time series analysis
Megan C Herink, Jonah Geddes, Kim Vo, et al.
Drugs
|
August 24, 2019
Clinical Management of Pharmacokinetic Drug Interactions with Direct Oral Anticoagulants (DOACs)
Megan C Herink, Yan F Zhuo, Craig D Williams, et al.
Systematic Reviews
|
April 16, 2015
The safety and efficacy of vortioxetine for acute treatment of major depressive disorder: a systematic review and meta-analysis
Amanda S Meeker, Megan C Herink, Dean G Haxby, et al.
Pharmacy (Basel, Switzerland)
|
October 26, 2022
Pharmacists' Knowledge and Perceptions of FDA Approval Standards and the Breakthrough Therapy Designation
Megan C Herink, Kirbee Johnston, Kristin Breninger, et al.
The Primary Care Companion for CNS Disorders
|
July 2, 2024
A 3-Times-Daily Dosing Scheme of Prazosin to Treat Posttraumatic Stress Disorder-Induced Psychological Distress in the Hospital
Kendall J Tucker, Trisha T Villanueva, Miles Fletcher, et al.
Pharmacotherapy
|
December 19, 2013
Evidence behind FDA alerts for drugs with adverse cardiovascular effects: implications for clinical practice
Daniel M Rackham, Megan C Herink, Ian G Stevens, et al.
Journal of Pharmacy Practice
|
March 17, 2023
Adherence to Hepatitis C Treatment Among Underserved Patients With Substance Use Disorder in a Pharmacist-led Treatment Model
Anthony J McKenzie, Brie N Noble, Megan C Herink, et al.
Page
of 2